Electrophysiological properties of catecholaminergic neurons in the norepinephrine-deficient mouse

Neuroscience

Volumn 144, Issue 3, 2007, Pages 1067-1074

  Paladini, C A ^a,b   Beckstead, M J ^b   Weinshenker, D ^c  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cocaine; dopamine hydroxylase knockout; locus coeruleus; substantia nigra pars compacta

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BRIMONIDINE; DOPAMINE BETA MONOOXYGENASE; METENKEPHALIN; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN SLICE; CATECHOLAMINE NERVE CELL; CELL ADHESION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; EMBRYO; KNOCKOUT MOUSE; LOCUS CERULEUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA; WHOLE CELL;

ACTION POTENTIALS; ADRENERGIC ALPHA-AGONISTS; ANIMALS; AUTORECEPTORS; DOPAMINE BETA-HYDROXYLASE; ELECTRIC STIMULATION; ENKEPHALIN, METHIONINE; LOCUS COERULEUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURAL INHIBITION; NOREPINEPHRINE; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; QUINOXALINES; RECEPTORS, ADRENERGIC, ALPHA-2; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION;

EID: 33845723108     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.10.032     Document Type: Article

References (58)

1. Alvarez-Maubecin V., Garcia-Hernandez F., Williams J.T., and Van Bockstaele E.J. Functional coupling between neurons and glia. J Neurosci 20 (2000) 4091-4098
2. Amara S.G., and Sonders M.S. Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend 51 (1998) 87-96
3. Aston-Jones G., and Cohen J.D. Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J Comp Neurol 493 (2005) 99-110
4. Berridge C.W., and Waterhouse B.D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42 (2003) 33-84
5. Bezin L., Diaz J.J., Marcel D., Le Cavorsin M., Madjar J.J., Pujol J.F., and Weissmann D. Controlled targeting of tyrosine hydroxylase protein toward processes of locus coeruleus neurons during postnatal development. Brain Res Mol Brain Res 50 (1997) 23-32
6. Castren E., Thoenen H., and Lindholm D. Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience 64 (1995) 71-80
7. Cubells J.F., and Zabetian C.P. Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology (Berl) 174 (2004) 463-476
8. Dang V.C., and Williams J.T. Morphine-induced mu-opioid receptor desensitization. Mol Pharmacol 68 (2005) 1127-1132
9. Dreyfus C.F., Markey K.A., Goldstein M., and Black I.B. Development of catecholaminergic phenotypic characters in the mouse locus coeruleus in vivo and in culture. Dev Biol 97 (1983) 48-58
10. Foote S.L., Bloom F.E., and Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63 (1983) 844-914
11. Girault J.A., and Greengard P. The neurobiology of dopamine signaling. Arch Neurol 61 (2004) 641-644
12. Grenhoff J., Nisell M., Ferre S., Aston-Jones G., and Svensson T.H. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm Gen Sect 93 (1993) 11-25
13. Grenhoff J., and Svensson T.H. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 233 (1993) 79-84
14. Jin S.H., Kim H.J., Harris D.C., and Thomas S.A. Postnatal development of the cerebellum and the CNS adrenergic system is independent of norepinephrine and epinephrine. J Comp Neurol 477 3 (2004) 300-309
15. Johnson S.W., and North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol 450 (1992) 455-468
16. Jones B.E., and Moore R.Y. Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study. Brain Res 127 (1977) 25-53
17. Kimura F., and Nakamura S. Postnatal development of alpha-adrenoceptor-mediated autoinhibition in the locus coeruleus. Brain Res 432 (1987) 21-26
18. Koylu E.O., Smith Y., Couceyro P.R., and Kuhar M.J. CART peptides colocalize with tyrosine hydroxylase neurons in rat locus coeruleus. Synapse 31 (1999) 309-311
19. Lauder J.M., and Bloom F.E. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiation. J Comp Neurol 155 (1974) 469-481
20. Lauder J.M., and Bloom F.E. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. II. Synaptogenesis. J Comp Neurol 163 (1975) 251-264
21. Le Saux F., Besson M.J., and Maurin Y. Abnormal postnatal ontogeny of the locus coeruleus in the epileptic mutant mouse quaking. Brain Res Dev Brain Res 136 (2002) 197-205
22. Levine E.S., Litto W.J., and Jacobs B.L. Activity of cat locus coeruleus noradrenergic neurons during the defense reaction. Brain Res 531 (1990) 189-195
23. Liprando L.A., Miner L.H., Blakely R.D., Lewis D.A., and Sesack S.R. Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area. Synapse 52 (2004) 233-244
24. Mann D.M., and Yates P.O. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders. Hum Neurobiol 5 (1986) 147-158
25. Marino M.D., Bourdelat-Parks B.N., Cameron Liles L., and Weinshenker D. Genetic reduction of noradrenergic function alters social memory and reduces aggression in mice. Behav Brain Res 161 (2005) 197-203
26. Mercuri N.B., Bonci A., Calabresi P., Stefani A., and Bernardi G. Properties of the hyperpolarization-activated cation current Ih in rat midbrain dopaminergic neurons. Eur J Neurosci 7 (1995) 462-469
27. Montague P.R., Hyman S.E., and Cohen J.D. Computational roles for dopamine in behavioural control. Nature 431 (2004) 760-767
28. Morita Y., Zhang J.H., Hironaka T., Tateno E., Noguchi K., Sato M., Kiyama H., and Tohyama M. Postnatal development of preproenkephalin mRNA containing neurons in the rat lower brainstem. J Comp Neurol 292 (1990) 193-213
29. Murchison C.F., Zhang X.Y., Zhang W.P., Ouyang M., Lee A., and Thomas S.A. A distinct role for norepinephrine in memory retrieval. Cell 117 (2004) 131-143
30. Nakamura S., Kimura F., and Sakaguchi T. Postnatal development of electrical activity in the locus ceruleus. J Neurophysiol 58 (1987) 510-524
31. Neuhoff H., Neu A., Liss B., and Roeper J. I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J Neurosci 22 (2002) 1290-1302
32. Osborne P.B., Vidovic M., Chieng B., Hill C.E., and Christie M.J. Expression of mRNA and functional alpha(1)-adrenoceptors that suppress the GIRK conductance in adult rat locus coeruleus neurons. Br J Pharmacol 135 (2002) 226-232
33. Paladini C.A., Robinson S., Morikawa H., Williams J.T., and Palmiter R.D. Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism. Proc Natl Acad Sci U S A 100 (2003) 2866-2871
34. Pitts D.K., and Marwah J. Electrophysiological actions of cocaine on noradrenergic neurons in rat locus ceruleus. J Pharmacol Exp Ther 240 (1987) 345-351
35. Ressler K.J., and Nemeroff C.B. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry 46 (1999) 1219-1233
36. Sanders J.D., Happe H.K., Bylund D.B., and Murrin L.C. Development of the norepinephrine transporter in the rat CNS. Neuroscience 130 (2005) 107-117
37. Schank J.R., Liles L.C., and Weinshenker D. Reduced anticonvulsant efficacy of valproic acid in dopamine beta-hydroxylase knockout mice. Epilepsy Res 65 (2005) 23-31
38. Soldani P., and Fornai F. The functional anatomy of noradrenergic neurons in Parkinson's disease. Funct Neurol 14 (1999) 97-109
39. Suzuki M., Hurd Y.L., Sokoloff P., Schwartz J.C., and Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res 779 (1998) 58-74
40. Swanson L.W., and Hartman B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J Comp Neurol 163 (1975) 467-505
41. Szot P., Weinshenker D., White S.S., Robbins C.A., Rust N.C., Schwartzkroin P.A., and Palmiter R.D. Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli. J Neurosci 19 (1999) 10985-10992
42. Thomas S.A., Marck B.T., Palmiter R.D., and Matsumoto A.M. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J Neurochem 70 (1998) 2468-2476
43. Thomas S.A., Matsumoto A.M., and Palmiter R.D. Noradrenaline is essential for mouse fetal development. Nature 374 (1995) 643-646
44. Thomas S.A., and Palmiter R.D. Disruption of the dopamine beta-hydroxylase gene in mice suggests roles for norepinephrine in motor function, learning, and memory. Behav Neurosci 111 (1997) 579-589
45. Thomas S.A., and Palmiter R.D. Impaired maternal behavior in mice lacking norepinephrine and epinephrine. Cell 91 (1997) 583-592
46. Thomas S.A., and Palmiter R.D. Examining adrenergic roles in development, physiology, and behavior through targeted disruption of the mouse dopamine beta-hydroxylase gene. Adv Pharmacol 42 (1998) 57-60
47. Torrecilla M., Marker C.L., Cintora S.C., Stoffel M., Williams J.T., and Wickman K. G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons. J Neurosci 22 (2002) 4328-4334
48. Weinshenker D., Miller N.S., Blizinsky K., Laughlin M.L., and Palmiter R.D. Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals. Proc Natl Acad Sci U S A 99 (2002) 13873-13877
49. Weinshenker D., Rust N.C., Miller N.S., and Palmiter R.D. Ethanol-associated behaviors of mice lacking norepinephrine. J Neurosci 20 (2000) 3157-3164
50. Weinshenker D., and Szot P. The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol Ther 94 (2002) 213-233
51. Weinshenker D., White S.S., Javors M.A., Palmiter R.D., and Szot P. Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo. Brain Res 946 (2002) 239-246
52. Williams J.T., North R.A., Shefner S.A., Nishi S., and Egan T.M. Membrane properties of rat locus coeruleus neurones. Neuroscience 13 (1984) 137-156
53. Winzer-Serhan U.H., and Leslie F.M. Alpha2B adrenoceptor mRNA expression during rat brain development. Brain Res Dev Brain Res 100 1 (1997) 90-100
54. Xu Z.Q., Shi T.J., and Hokfelt T. Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors. J Comp Neurol 392 (1998) 227-251
55. Yokoyama C., Okamura H., Nakajima T., Taguchi J., and Ibata Y. Autoradiographic distribution of [3H]YM-09151-2, a high-affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord. J Comp Neurol 344 (1994) 121-136
56. Zhang W., Xie Y., Gu J., Ai S., Wang J., Yamamoto K., and Jin L. Liquid chromatography with amperometric detection at a nano crystalline Ce-doped lead dioxide film modified electrode for determination of (R)-Salsolinol, (R)-N-methylsalsolinol and monoamine neurotransmitters in parkinsonian patients' cerebrospinal fluid. Analyst 129 (2004) 229-234
57. Zheng P., Zhang X.X., Bunney B.S., and Shi W.X. Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience 91 (1999) 527-535
58. Zyzek E., Richard F., Bouilloux J.P., and Pujol J.F. Ontogeny of tyrosine hydroxylase concentration in locus coeruleus of newborn rats: long-term effects of RU24722. J Neurochem 55 (1990) 849-853